The paper demonstrating the benefits of shorter-course radiotherapy can be found by following the link: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial https://doi.org/10.1016/S0140-6736(09)60484-0
Professor Sebag-Montefiore is Clinical Director of the Leeds Cancer Research UK Centre of Excellence for Radiotherapy Research, Chair of the National Cancer Research Institute Clinical and Translational Radiotherapy Group (CTRad) and Clinical Director of the Cancer Research UK Leeds Clinical Trial Unit.
About The University of Leeds
The University of Leeds is one of the largest higher education institutions in the UK, with more than 38,000 students from more than 150 different countries, and a member of the Russell Group of research-intensive universities. The University plays a significant role in the Turing, Rosalind Franklin and Royce Institutes.
We are a top ten university for research and impact power in the UK, according to the 2014 Research Excellence Framework, and are in the top 100 of the QS World University Rankings 2020. The University was awarded a Gold rating by the Government's Teaching Excellence Framework in 2017, recognising its 'consistently outstanding' teaching and learning provision. Twenty-six of our academics have been awarded National Teaching Fellowships - more than any other institution in England, Northern Ireland and Wales - reflecting the excellence of our teaching.
Back to HCB News
